| Bioactivity | Docosatetraenylethanolamide (DEA) is a cannabinoid receptor 1 (CB1) agonist. Docosatetraenylethanolamide inhibits the specific binding of cannabinoid probe to rat synaptosomal membranes with a Ki value of 34.4 nM. Docosatetraenylethanolamide can be used in the research of nervous system[1][2]. |
| Invitro | Docosatetraenylethanolamide inhibits the electrically evoked twitch response of the mouse isolated vas deferens (IC50=95.5 nM). |
| Name | Docosatetraenylethanolamide |
| CAS | 150314-35-5 |
| Formula | C24H41NO2 |
| Molar Mass | 375.59 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Docosatetraenylethanolamide
CAS: 150314-35-5 F: C24H41NO2 W: 375.59
Docosatetraenylethanolamide (DEA) is a cannabinoid receptor 1 (CB1) agonist. Docosatetraenylethanolamide inhibits the sp
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.